Biohaven Pharmaceutical Holding Company Ltd. (d/b/a Biohaven) announced today that the Food and Drug Administration (“FDA”) has granted the company’s orphan drug designation request covering BHV-0223...
(PRWeb March 03, 2016)
Read the full story at http://www.prweb.com/releases/2016/03/prweb13246650.htm